Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Sr MD Strategy & Execution | September 15, 2016 | September 19, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 15, 2016 · Filed September 19, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 16,240 |
Ending reported balance
After 2016-09-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-09-15 · Grant · Acquired 5,492 · Balance 16,559 Row 2 · 2016-09-16 · Tax withholding · Disposed 319 · Balance 16,240 F1: Mr. Zagotta surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Zagotta surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2016 Filed Sep 19, 2016 20:24 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 319 | $109.65 | $34,978.35 |
DisclosureSEC source: 0001156375-16-000239 · edgardoc.xml · nonDerivative · entry 2 Zagotta Robert · CIK 0001553680 · Sr MD Strategy & Execution 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,240 F1 · shares: Mr. Zagotta surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2016. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:40 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 937 | $109.28 | $102,395.36 |
DisclosureSEC source: 0001156375-16-000225 · edgardoc.xml · nonDerivative · entry 2 Zagotta Robert · CIK 0001553680 · Sr MD Strategy & Execution 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,067 F2 · shares: Mr. Zagotta surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2016. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 20:24 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 5,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-16-000239 · edgardoc.xml · nonDerivative · entry 1 Zagotta Robert · CIK 0001553680 · Sr MD Strategy & Execution 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,559 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 19:40 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 371 | $107.55 | $39,901.05 |
DisclosureSEC source: 0001156375-16-000225 · edgardoc.xml · nonDerivative · entry 1 Zagotta Robert · CIK 0001553680 · Sr MD Strategy & Execution 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,004 F1 · shares: Mr. Zagotta surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.